Приказ основних података о документу

dc.creatorPislar, Anja
dc.creatorNedeljković, Biljana Bozic
dc.creatorPerić, Mina
dc.creatorJakos, Tanja
dc.creatorZidar, Nace
dc.creatorKos, Janko
dc.date.accessioned2022-11-15T15:28:26Z
dc.date.available2022-11-15T15:28:26Z
dc.date.issued2022
dc.identifier.issn0893-7648
dc.identifier.urihttps://imagine.imgge.bg.ac.rs/handle/123456789/1535
dc.description.abstractMicroglia are resident macrophages in the central nervous system that are involved in immune responses driven by Toll-like receptors (TLRs). Microglia-mediated inflammation can lead to central nervous system disorders, and more than one TLR might be involved in these pathological processes. The cysteine peptidase cathepsin X has been recognized as a pathogenic factor for inflammation-induced neurodegeneration. Here, we hypothesized that simultaneous TLR3 and TLR4 activation induces synergized microglia responses and that these phenotype changes affect cathepsin X expression and activity. Murine microglia BV2 cells and primary murine microglia were exposed to the TLR3 ligand polyinosinic-polycytidylic acid (poly(I:C)) and the TLR4 ligand lipopolysaccharide (LPS), individually and simultaneously. TLR3 and TLR4 co-activation resulted in increased inflammatory responses compared to individual TLR activation, where poly(I:C) and LPS induced distinct patterns of proinflammatory factors together with different patterns of cathepsin X expression and activity. TLR co-activation decreased intracellular cathepsin X activity and increased cathepsin X localization at the plasma membrane with concomitant increased extracellular cathepsin X protein levels and activity. Inhibition of cathepsin X in BV2 cells by AMS36, cathepsin X inhibitor, significantly reduced the poly(I:C)- and LPS-induced production of proinflammatory cytokines as well as apoptosis. Additionally, inhibiting the TLR3 and TLR4 common signaling pathway, PI3K, with LY294002 reduced the inflammatory responses of the poly(I:C)- and LPS-activated microglia and recovered cathepsin X activity. We here provide evidence that microglial cathepsin X strengthens microglia activation and leads to subsequent inflammation-induced neurodegeneration. As such, cathepsin X represents a therapeutic target for treating neurodegenerative diseases related to excess inflammation.en
dc.publisherSpringer, New York
dc.relationResearch Agency of the Republic of Slovenia [P4-0127, J4-4123, J3-9267]
dc.relationMinistry of Education and Science of the Republic of Slovenia [451-03-68/2020-14/200178]
dc.relationRepublic of Slovenia
dc.relationRepublic of Serbia
dc.rightsopenAccess
dc.rights.urihttps://creativecommons.org/licenses/by/4.0/
dc.sourceMolecular Neurobiology
dc.subjectToll-like receptorsen
dc.subjectProinflammatory mediatorsen
dc.subjectNeuroprotectionen
dc.subjectNeuroinflammationen
dc.subjectMicrogliaen
dc.subjectCathepsin Xen
dc.titleCysteine Peptidase Cathepsin X as a Therapeutic Target for Simultaneous TLR3/4-mediated Microglia Activationen
dc.typearticle
dc.rights.licenseBY
dc.citation.epage2276
dc.citation.issue4
dc.citation.other59(4): 2258-2276
dc.citation.rankM21
dc.citation.spage2258
dc.citation.volume59
dc.identifier.doi10.1007/s12035-021-02694-2
dc.identifier.fulltexthttps://imagine.imgge.bg.ac.rs/bitstream/id/125/1532.pdf
dc.identifier.pmid35066760
dc.identifier.scopus2-s2.0-85123495969
dc.identifier.wos000745595600002
dc.type.versionpublishedVersion


Документи

Thumbnail

Овај документ се појављује у следећим колекцијама

Приказ основних података о документу